News

EyeSouth Partners, a portfolio company of Shore Capital Partners, has invested in Montgomery Eye Physicians and Prescription Eyewear. Financial terms weren’t announced. Montgomery Eye is an ophthalmology practice in the Montgomery, Alabama metropolitan area.

PRESS RELEASE

EyeSouth Establishes Presence in Alabama Through Affiliation with Montgomery Eye Physicians

EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has completed an affiliation with Montgomery Eye Physicians and Prescription Eyewear (collectively “Montgomery Eye” or the “Practice”). The affiliation will be EyeSouth’s first in Alabama, which will be a priority growth state for the Company in the future. EyeSouth is an eye care-focused management services organization committed to partnering with leading physicians to build a premier network of eye care services in the Southeast. EyeSouth’s affiliate network consists of approximately 75 doctors providing medical and surgical eye care services at approximately 50 locations throughout Georgia, North Carolina, Florida, Tennessee and Alabama.

Montgomery Eye is led by its partners Dr. Tom Mitchell, Dr. John Swan, and Dr. In Shin and functions with four total ophthalmologists including the three partners and Dr. Katherine Donnithorne and three medical optometrists, Dr. Michael Bradford, Dr. Tim Meadows and Dr. Tyler McFaden. The Practice employs approximately 75 support staff across three locations in Montgomery and Prattville. Founded in 1945, Montgomery Eye was the first comprehensive ophthalmology practice in the Montgomery metropolitan area (the “River Region”). With EyeSouth’s support, Montgomery Eye will continue to ensure the highest quality of eye care is delivered to its patients throughout the region.

Dr. Mitchell, who has been practicing at Montgomery Eye since 1987, commented on the partnership, “Finding a strategic management partner that was going to help ensure the long-term success of the Practice for our patients and employees was critical. We are thrilled to have found EyeSouth and to join their network of high-quality practices throughout the Southeast.”

“We are honored to partner with Montgomery Eye and expand into Alabama,” said Eugene Gabianelli, M.D., Chief Medical Officer of EyeSouth Partners. “The Practice’s reputation for clinical quality and long-standing history speaks for itself and we look forward to continuing to build off of the success the practice has already achieved.”

Montgomery Eye Physicians will continue to operate under its brand, with no changes to its staff, physicians or locations.

To learn more about a partnership with EyeSouth Partners, visit www.eyesouthpartners.com or contact Charlie Shreve, VP of Business Development & Strategy,[email protected].

About EyeSouth Partners

Headquartered in Atlanta, GA, EyeSouth Partners (“EyeSouth”) is an eye care management services organization committed to partnering with leading physicians to build a premier network of eye care services in the Southeast. EyeSouth’s partner practices’ clinical mission is to provide high quality medical and surgical specialty eye care. EyeSouth supports its affiliated practices and physician partners with strategic guidance, administrative resources, operating expertise, and capital with an absolute focus on clinical quality and a patient-first culture. EyeSouth’s affiliate network consists of approximately 75 doctors providing medical and surgical eye care services at approximately 50 locations throughout Georgia, North Carolina, Florida, Tennessee and Alabama. EyeSouth is backed by Shore Capital Partners, a leading lower middle market healthcare private equity firm. For more information about EyeSouth Partners, please visit: www.eyesouthpartners.com.

About Shore Capital Partners

Shore Capital is a Chicago-based private equity firm focused on microcap healthcare and food & beverage investments. Shore supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value to shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant growth potential, including organic and growth through industry consolidation. Shore has ~$1 billion of equity capital under management through various investment vehicles. For more information, please visit: www.shorecp.com.